Facility enables company to formulate plant cell-cultivated ingredients.

Will consolidate peanut-based formulas to one location.

Company’s first fermentation biomanufacturing facility.

Six companies face regulatory action for selling copycat products formulated with Delta-8 THC.

Company emphasized low-sugar snacks and portion control.

Project will expand facility by 50,000 square feet.

New plant set to open by 2025.

The move is part of Casey’s three-year strategic plan.

Innovation building is hub for formulating new flavors.

Chain to enter Switzerland and Mexico.